Release date: 2015-09-30 Recently, the GEN website released the “Top 25 Biotech Companies of 2015†list based on the market value of the company; the data is based on information released by the company to the stock exchange market as of September 8 and other publicly available resources. In this year's list, there are four companies with a market capitalization of more than 100 billion. Gillette tops the list with $149.78 billion. The other three companies are Novo Nordisk, Allergan and Amgen, respectively. This time, among the top 25 companies, the market capitalization was the lowest at $9.76 billion, and in 2013 the last market value of the list was only $2.3 billion. At the same time, this year's list shows that biotech companies can also make a big increase in market value through mergers and acquisitions. In November 2014, Actavis, ranked 10th on the list last year, acquired Allergan, which ranked sixth in the same year for $66 billion. The two companies had a market capitalization of $38.15 billion and $50.75 billion last year. After the transformation of this year, "Allergan" jumped to the third place on the list, and the market value has exceeded 100 billion US dollars. In addition, last year's list of Salix Pharmaceuticals (22 last year) and Pharmacyclics (24th last year) have been acquired by Valeant and Alberta. The companies that entered the list this year include Perrigo, Mylan and Incyte, ranking 15th and 17th respectively. In fact, Mylan's offer to Perrigo has been the focus of the industry. Mylan announced in April that she hopes to acquire Perrigo, but Perrigo rejected her offer on the grounds that the bid is too low and that Perrigo will perform better independently. Recently, according to Reuters news, Mylan said that the company will face Perrigo investors directly from September 14th, the company wants to buy stocks of these investors with $27 billion in cash and stock. In addition, it is worth noting that Sinopharm Holding Co., Ltd., which was listed in Hong Kong in 2009, ranked 25th on the list with a market capitalization of US$9.76 billion. Compared with last year, although the ranking dropped by 2, the market value increased by US$1.87 billion. Source: Bio-Exploration
China Antibacterial Blend Suppliers
Here you can find the related products in Antibacterial Blend, we are professional manufacturer of Antibacterial blend. We focused on international export product development, production and sales. We have improved quality control processes of Antibacterial Blend to ensure each export qualified product.
If you want to know more about the products in Antibacterial Blend, please click the Product details to view parameters, models, pictures, prices and Other information about Antibacterial Blend.
Whatever you are a group or individual, we will do our best to provide you with accurate and comprehensive message about Antibacterial Blend!
Salicylic Acid,BHA,O-hydroxybenzoic acid,Allantoin Xi'an Gawen Biotechnology Co., Ltd , https://www.ahualyn-bio.com
GEN: TOP25, the world's most marketable biotechnology company in 2015
Next Article
Orchard management after harvest